Il-Suk Sohn

18PUBLICATIONS
128CO-AUTHORS
Predictive and prognostic markersToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 23, 2026
Temporal Trend of Cardiovascular Disease Burden Among Cancer Patients Between 2005 and 2022: Nationwide Population-Based Cohort Study in South Korea.

Iksung Cho, Seonhwa Lee, Jaehyeong Cho

|Feb 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT.

Jeong Cheon Ahn, Cheol Whan Lee, Jong-Hwa Ahn

|May 21, 2024
Breast Cancer and Therapy-Related Cardiovascular Toxicity.

Hui-Jeong Hwang, Sang-Ah Han, Il Suk Sohn

|May 08, 2023
Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic.

Jinho Shin, Hae Young Lee, Sungha Park

|Mar 30, 2023
Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing frequency important?

Hui-Jeong Hwang, Il Suk Sohn, Eun-Sun Jin

|Feb 15, 2023
Advancing Cardio-Oncology in Asia.

Choon Ta Ng, Li Ling Tan, Il Suk Sohn

Pageof 3

Frequent Collaborators

5 joint publications

Jinho Shin

5 joint publications

Hui-Jeong Hwang

4 joint publications

Ju-Hee Lee

3 joint publications

Hyemoon Chung